National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

Found 6,183 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Myocarditis or Pericarditis



Case Details

This is page 6 out of 619

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 1071409 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: California  
Vaccinated:2021-02-21
Onset:2021-02-24
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain upper, Blood creatine phosphokinase MB increased, Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation, Headache, Pericarditis, Pyrexia, Troponin T increased, Troponin increased
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: obesity
Allergies: none
Diagnostic Lab Data: The patient was found to have significantly elevated Troponins and elevated CKMB. His troponin and CKMB down trended during his admission. Echocardiogram was performed to show no significant abnormalities. EKG changes noted were diffuse ST segment elevations, which persisted throughout his entire hospital stay. Troponin T Latest Ref Range: <=0.03 ng/mL 2/25/2021 03:33 : 2.54 (H) 2/25/2021 10:10 : 2.92 (H) 2/25/2021 17:55 : 3.38 (H) 2/26/2021 03:15 : 3.27 (H) 2/26/2021 10:15 : 2.57 (H) 2/26/2021 17:56 : 2.39 (H) 2/27/2021 02:00 : 2.01 (H) 2/27/2021 10:45: 2.02 (H) CKMB Latest Ref Range: 0.0 - 7.5 ng/mL 2/25/2021 03:33 - 123.4 (H) 2/25/2021 10:10 - 104.1 (H) 2/25/2021 17:55 - 63.7 (H) 2/26/2021 03:15 - 25.9 (H) 2/26/2021 10:15 - 17.3 (H) 2/26/2021 17:56 - 9.7 (H) 2/27/2021 02:00 - 5.8 2/27/2021 10:45 - 4.9 Echo 2/25 1. This was a technically difficult study, possibly affecting interpretation. 2. Normal segmental cardiac anatomy. 3. Normal right ventricular systolic shortening. 4. Left ventricular systolic function was low normal. 5. No evidence of elevated pulmonary artery pressure ECG 2/25 Normal sinus rhythm Low voltage QRS, consider pulmonary disease, pericardial effusion, or normal variant ST elevation consider inferolateral injury or acute infarct ** ** ACUTE MI / STEMI ** ** Abnormal ECG ECG: 2/26 Normal sinus rhythm Low voltage QRS, consider pulmonary disease, pericardial effusion, or normal variant ST elevation consider lateral injury or acute infarct ** ** ACUTE MI / STEMI ** ** Abnormal ECG
CDC Split Type:

Write-up: Since receiving his second dose of COVID-19 vaccine (Pfizer) on Sunday 2/21 he has had fever (tmax 103.0 F), headache, and stomach ache. His fever started on 2/21 and had persisted through 2/24. He woke up from a nap on 2/24 in the afternoon at 1600 had onset of severe chest pain. Then reoccurring multiple times throughout the evening. He was taken to a local hospital and the transferred to another hospital for higher level of care. Pediatric cardiology was consulted and treatment was started for suspected atypical pericarditis with colchicine 0.6mg BID and ibuprofen 600mg QID w/ famotidine 40mg QDay. His chest pain resolved the day of admission, even prior to starting treatment. Patient was discharged in clinically stable condition to follow up with pediatric cardiology in 2 weeks as outpatient.


VAERS ID: 1074011 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Female  
Location: Connecticut  
Vaccinated:2021-01-28
Onset:2021-01-30
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9263 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute myocardial infarction, Atrial fibrillation, Chest pain, Myocardial ischaemia, Pericarditis, Troponin increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Supraventricular tachyarrhythmias (narrow), Embolic and thrombotic events, arterial (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Other ischaemic heart disease (narrow), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: acetaminophen (TYLENOL) 500 MG allopurinoL (ZYLOPRIM) 300 mg tablet T amoxicillin-clavulanate (AUGMENTIN) 500-125 mg per tablet T aspirin 81 mg EC delayed release tablet calcium carbonate-vitamin D3 600 mg(1,500mg) -800 unit T
Current Illness: Admitted with septic shock 1/3/21, BC negative. Rapidly improved
Preexisting Conditions: CAD s/p MI, HTN, PVD s/p aorto-iliac bypass graft (1983), fem-fem bypass for occlusion of left limb of graft (1993), left axillo femoral bypass graft (2003) complicated by aortic graft infection from likely aorto-enteric fistula (2018) now on chronic antibiotic suppression Celiac disease
Allergies: None
Diagnostic Lab Data: troponin 0.23
CDC Split Type:

Write-up: Presented to ED 48 h after vaccine with chest pain, found to have pericarditis Develop atrial fibrillation, nSTEMI from demand ischemia


VAERS ID: 1076954 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-02-03
Onset:2021-02-06
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Adenovirus test, Antinuclear antibody negative, COVID-19, Cardiac imaging procedure abnormal, Chest discomfort, Chest pain, Chlamydia test negative, Coxsackie virus test, Cytomegalovirus test negative, Dyspnoea, Electrocardiogram change, Epstein-Barr virus test negative, Fatigue, Herpes simplex test negative, Herpes virus test, Hyperhidrosis, Hypoaesthesia, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Legionella test, Myocarditis, Nausea, Pain in extremity, Paraesthesia, Parvovirus B19 test, Polymerase chain reaction, Respiratory syncytial virus test negative, Rheumatoid factor, SARS-CoV-2 antibody test positive, SARS-CoV-2 test negative, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ibuprofen as needed for pain
Current Illness: N/A
Preexisting Conditions: None
Allergies: N/A
Diagnostic Lab Data: 02/08: C pneumonia DNA by PCR - not detected, CMV IgM Ab - not detected 02/08: Coxsackie B1: Titer = 1:160 02/08: Coxsackie B2, B3, B3, B4, B5, B6: Titer = less than 1:10 02/08: EBV DNA PCR - not detected, Legionella (-) 02/08: Parvovirus B19 IgG Ab: 8.87 - per reference range: may indicate current or past infection 02/08: Parvovirus B19 IgM Ab: 0.18 - per reference range: negative 02/08: Influenza A/B: none detected 02/08: RSV (-) 02/08: COVID 19 Corona virus PCR: not detected 02/10: COVID 19 Ab IgG: Positive 02/09 cardiac MRI revealed Infero-lateral myocarditis pending official report. 02/10 Rheumatoid Factor < 10, 03/07 ANA, by IFA: <1:80, negative, 02/14: Adenovirus Ab (-), HSV1 IgG (-), HSV2 IgG (-), HSV IgM(-) 02/14: Herpes Virus 6: < 1000 - not detected
CDC Split Type:

Write-up: Patient is a 27 year old male with no significant medical history presents to MC on 2/6 from Urgent Care for further evaluation of chest pain. He states that he woke up at 5:30am with abrupt onset of chest pain with present like quality in the middle of the chest. It was non-radiating with associated nausea, small amount of emesis, and dyspnea. His pain lasted for about 15 minutes and he started experiencing it again after half an hour with numbness and tingling of his bilateral distal digits and diaphoresis. He decided to seek evaluation at local Urgent Care around 7:30am. States that he was immediately send here through ambulance due to findings of EKG changes. He was given aspirin and nitroglycerin with some alleviation of pain. Currently, he feels little better although continues to have chest pressure substernally every 45 minutes lasting 5-10 minutes. His dyspnea is resolved. He does not have pleuritic chest pain, fever, chills, nausea, vomiting, abdominal pain, diarrhea, leg swelling, rash. Additionally, he has been in normal state of health until this 2/2/21 when he received second dose of COVID-19 (Pfizer) vaccine. He had extreme fatigue with left arm soreness. He reports no sick contacts, recent illness, or travel. MRI cardiac done 2/9/21 with assessment reveals Infero-lateral myocarditis. Patient remained hemodynamically stable and was discharged with ibuprofen taper for 10 days, c/w colchicine 0.6 mg QD x 3 months and pantoprazole 40 mg QD


VAERS ID: 1081208 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: California  
Vaccinated:2021-03-04
Onset:2021-03-06
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Cold sweat, Electrocardiogram ST segment elevation, Human rhinovirus test positive, Malaise, Myocarditis, Nausea, Pain, Pericarditis, Pyrexia, SARS-CoV-2 test negative, Sleep disorder, Troponin increased
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol inhaler
Current Illness: diagnosed in ED with Rhinovirus
Preexisting Conditions: Asthma
Allergies: Gluten, Legumes
Diagnostic Lab Data: Molecular testing was negative for COVID-19 but positive for a rhinovirus. His troponin was initially elevated to 11.98. A subsequent troponin reached 22. Pt was transferred medical facility for cardiac MRI. Final diagnosis at medical center: Pericarditis, myocarditis, positive rhino virus testing
CDC Split Type:

Write-up: This is a 18 y.o. male who is generally healthy. He received a second dose of the SARS2-COV vaccine on 3/4. The following morning he felt feverish and achy with malaise. He stayed home, drank fluids and rested and felt well enough to come up to ski this weekend. During skiing he had some anterior chest pain, it resolved and he went about his day. Tonight at 2245 the pain became sharp and awakened him from sleep. He felt nauseated and clammy as well. Father brought him to the ER for evaluation. His emergency department evaluation showed ST elevations most notably in the inferior and lateral leads as well as in the lateral precordium.


VAERS ID: 1083746 (history)  
Form: Version 2.0  
Age: 21.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-01-13
Onset:2021-02-03
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Pericarditis, SARS-CoV-2 test, Transaminases increased
SMQs:, Liver related investigations, signs and symptoms (narrow), Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Food allergy; Idiopathic thrombocytopenic purpura
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: Nasal Swab, covid test; Test Result: Negative
CDC Split Type: USPFIZER INC2021200683

Write-up: Pericarditis; Transaminitis; This is a spontaneous report from a contactable Other- Health Professional (patient). A 21-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248) via an unspecified route of administration on 13Jan2021 15:15 at single dose on left arm, for covid-19 immunisation. Medical history included chronic immune Idiopathic thrombocytopenic purpura (ITP), allergies to Mushroom. The patient did not have covid prior vaccination. The patient''s concomitant medications were not reported. The patient experienced pericarditis and transaminitis on 03Feb2021. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the events for 6 days. The patient received treatment medications for the events. The lab test included Nasal Swab, covid test: negative on 05Feb2021. The outcome of events was not recovered.; Sender''s Comments: Based on the limited information provided, causality relationship cannot be clearly established and cannot be excluded.The case will be reassessed should additional information become available.~ The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1087143 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Male  
Location: Idaho  
Vaccinated:2021-02-02
Onset:2021-02-02
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Influenza, Myocarditis, SARS-CoV-2 test
SMQs:, Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: TESTOSTERONE
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Allergies:
Diagnostic Lab Data: Test Date: 20210212; Test Name: Blood test; Test Result: Negative ; Test Date: 20210212; Test Name: Nasal Swab; Test Result: Negative
CDC Split Type: USPFIZER INC2021200318

Write-up: myocarditis; severe chest pain; developed severe flu symptoms; This is a spontaneous report from a contactable healthcare professional (patient). A 39-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number and expiration date were unknown), via an unspecified route of administration in the left arm on 02Feb2021 at 08:30 AM (at the age of 39 years old) at a single dose for COVID-19 immunization. The vaccine was administered to the patient at a hospital. The patient had no medical history and had no known allergies. The patient had no COVID prior to vaccination. Concomitant medication included testosterone. The patient had no other vaccine in four weeks. The patient previously received the first dose of BNT162B2 on 12Jan2021 at 12:30 AM (at the age of 39 years old) in the left arm for COVID-19 immunization. The patient developed severe flu symptoms on 02Feb2021 at 20:30. The patient experienced chest pain and myocarditis on 12Feb2021 at 03:00 AM. It was reported that after 12 hours, the patient developed severe flu symptoms for the following 48 hours. Then she developed severe chest pain and was hospitalized for myocarditis. The patient was hospitalized in Feb2021 for 5 days. The patient received treatment for the events which included heart medications and heart angiogram. The patient was tested for COVID post vaccination which included blood test and nasal swab, both with negative results on 12Feb2021. The outcome of the event was recovering. Information on the batch/lot number has been requested.; Sender''s Comments: The event myocarditis was most likely due to influenza, which was an intercurrent infection, and unrelated to suspect vaccine BNT162B2. There is no plausible mechanism implicating BNT162B2 to the reported event based on the drug known safety profile. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1087983 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-03-02
Onset:2021-03-05
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Angiocardiogram, C-reactive protein increased, Echocardiogram, Pericarditis, Red blood cell sedimentation rate
SMQs:, Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Acetaminophen, Vitamin D3, Enalapril, Lexapro, Estradiol cream, Furosemide, Glimepiride, Probiotic, Imodium, Metoprolol, nystatin ointment and powder, potassium chloride, Trulicity, Rosuvastatin., Warfarin
Current Illness: UTI, completed course of gentamicin (completed end of Feb)
Preexisting Conditions: CHF, hyperlipidemia, Afib, hypertension, obesity, sleep apnea, DM type 2, osteoarthritis
Allergies: Soma, Equagesic
Diagnostic Lab Data: Echo, ESR,CRP (elevated), CTCA
CDC Split Type:

Write-up: Acute inflammatory pericarditis with hospitalization from 3/7-3/10.


VAERS ID: 1088210 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-02-05
Onset:2021-02-23
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9264 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Adenovirus test, Cytomegalovirus test negative, Epstein-Barr virus antibody, Epstein-Barr virus antigen positive, Epstein-Barr virus test positive, Intensive care, Myocarditis, Oropharyngeal pain, Pyrexia, Respiratory viral panel, SARS-CoV-2 test negative
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 20 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 10 mg PO QPM 3. Vitamin D Dose is Unknown PO DAILY 4. Ascorbic Acid Dose is Unknown PO DAILY
Current Illness: Experienced mild COVID-19 infection (loss of taste/smell) in January, 2021 - diagnosed January 5th. Cleared to return to work 01/25/21.
Preexisting Conditions: None
Allergies: Clindamycin: skin rash
Diagnostic Lab Data: 02/26/2021 18:00 Adenovirus PCR (see report) serum - negative 02/26/2021 18:00 Cytomegalovirus DNA, Quantitative, Real-Time PCR (see report) serum - negative 02/26/2021 18:00 EBV PCR, Quantitative (see report) serum + at 980 copies 03/03/20: EBV IgG+; IgM - 02/24/20: COVID PCR nasal swab negative; multiplex respiratory viral pathogen panel negative
CDC Split Type:

Write-up: Patient presented to BIDMC on 02/23/21 with ~5d of sore throat and intractable fever and was found to have fulminant myocarditis. She required ICU stay with VA ECMO and Impella circulatory support from 02/25/21-03/03/21. She received a course of hydrocortisone. Cause of myocarditis was unclear but felt to be viral or post-viral versus inflammatory. As of this submission she has been transferred to the cardiac floor and seems to be recovering. Symptoms started ~14d after 1st dose COVID vaccine. She also had self limited COVID infection in early January, 2021.


VAERS ID: 1088842 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Male  
Location: California  
Vaccinated:2021-02-14
Onset:2021-02-17
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 AR / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute myocardial infarction, C-reactive protein increased, Catheterisation cardiac abnormal, Chest pain, Coronary arterial stent insertion, Coronary artery stenosis, Dyspnoea, Echocardiogram, Electrocardiogram abnormal, Pericarditis, Red blood cell sedimentation rate increased, Troponin normal
SMQs:, Anaphylactic reaction (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Other ischaemic heart disease (narrow), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Type 2 diabetes (diet-controlled), hypertension
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: The patient is a 77-year-old male with T2DM (not on medications), gout, and HTN who received the first dose of the Pfizer COVID-19 vaccine on 2/14. On 2/17 (three days after vaccination), he sought care in the emergency department for chest pain that worsened when he was supine and shortness of breath. EKG in the emergency room showed STEMI and troponin levels were normal. He was transferred to a different facility for cardiac catheterization. Cath showed mild circumflex disease and a stent was placed. He was diagnosed with pericarditis at that time (elevated inflammatory markers ESR/CRP). He was discharged home post cath on Plavix/ASA. He had an echocardiogram at his PCP?s office on 2/25, results still pending (as of 3/10). 2/25 ? televist with cardiologist who concurred with pericarditis, maybe mild coronary artery disease (follow-up scheduled 3/11). 3/3 chest pain symptom improved further, no cough, improved shortness of breath. Medications at home: statin, previously colchine for gout, likely BP medication (PCP will send records) Allergies: None known. Vaccine Indication: Age $g75


VAERS ID: 1093331 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-01-11
Onset:2021-02-21
   Days after vaccination:41
Submitted: 0000-00-00
Entered: 2021-03-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EZ3248 / 2 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Pericarditis, SARS-CoV-2 test
SMQs:, Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ATORVASTATIN; SYNTHROID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hyperlipidemia; Hypothyroidism
Allergies:
Diagnostic Lab Data: Test Date: 20210222; Test Name: Nasal Swab covid test; Result Unstructured Data: Test Result:Negative
CDC Split Type: USPFIZER INC2021216346

Write-up: Acute pericarditis; This is a spontaneous report from a contactable Physician reporting for himself A 37-year-old Male Physician received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EZ3248) on 11Jan2020 at single dose, via an unspecified route of administration, on left arm for COVID-19 immunization. Relevant medical history included hypothyroidism and hyperlipidemia. The patient received first dose of BNT162B2 on Dec2020 via an unspecified route of administration on left arm for COVID-19 immunization. Concomitant medications included atorvastatin and levothyroxine sodium (SYNTHROID). On 21Feb2021 at 17:00, the patient experienced acute pericarditis resulted in doctor office/clinic visit. Treatment received included Ibuprofen, Colchicine and Pantoprazole. At the time of the reporting, the patient was recovering from the event.; Sender''s Comments: Based on the limited information currently available, a possible association of the suspect drug administration with the reported event cannot be excluded, due to a plausible temporal relationship. This case will be reassessed when additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&SYMPTOMS[]=Myocarditis_%2810028606%29&SYMPTOMS[]=Pericarditis_%2810034484%29&VAX=COVID19&VAXMAN=PFIZER/BIONTECH

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166